SANUWAVE Health, Inc. Common Stock (SNWV) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.216x

Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has a cash flow conversion efficiency ratio of 0.216x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($397.00K) by net assets ($1.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is SANUWAVE Health, Inc. Common Stock worth for the company's overall valuation and market capitalisation.

SANUWAVE Health, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how SANUWAVE Health, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SANUWAVE Health, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their cash flow conversion efficiency. Explore SANUWAVE Health, Inc. Common Stock (SNWV) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Zenith Energy Ltd
OL:ZENA
-0.156x
Co2 Capsol AS
OL:CAPSL
-0.288x
DAEMO Engineering Co. Ltd
KQ:317850
0.068x
Global SM Tech Limited
KQ:900070
0.009x
VBARE Iberian Properties SOCIMI SA
MC:YVBA
-0.005x
Qmines Ltd
AU:QML
-0.145x
Killi Resources Ltd
AU:KLI
-0.250x
Wolford Aktiengesellschaft
VI:WOL
0.044x

Annual Cash Flow Conversion Efficiency for SANUWAVE Health, Inc. Common Stock (2006–2025)

The table below shows the annual cash flow conversion efficiency of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. View SNWV share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.62 Million $3.88 Million 2.394x +1340.14%
2024-12-31 $-12.72 Million $2.46 Million -0.193x -283.68%
2023-12-31 $-43.18 Million $-4.54 Million 0.105x -74.90%
2022-12-31 $-41.01 Million $-17.17 Million 0.419x +154.48%
2021-12-31 $-38.96 Million $-6.41 Million 0.165x -82.25%
2020-12-31 $-13.72 Million $-12.72 Million 0.927x +45.53%
2019-12-31 $-10.06 Million $-6.41 Million 0.637x +170.14%
2018-12-31 $-15.36 Million $-3.62 Million 0.236x +52.39%
2017-12-31 $-9.88 Million $-1.53 Million 0.155x -66.57%
2016-12-31 $-6.91 Million $-3.20 Million 0.463x -21.67%
2015-12-31 $-5.88 Million $-3.47 Million 0.591x -86.27%
2014-12-31 $-1.55 Million $-6.68 Million 4.305x +572.21%
2013-12-31 $-6.13 Million $-3.92 Million 0.640x -2.69%
2012-12-31 $-6.52 Million $-4.29 Million 0.658x -88.55%
2011-12-31 $-1.54 Million $-8.83 Million 5.748x +930.25%
2010-12-31 $-10.52 Million $-5.87 Million 0.558x -47.66%
2009-12-31 $-5.88 Million $-6.27 Million 1.066x +85.53%
2008-12-31 $-72.97K $-41.92K 0.575x +20.83%
2007-12-31 $-46.42K $-22.07K 0.475x +25.28%
2006-12-31 $-10.73K $-4.07K 0.380x --

About SANUWAVE Health, Inc. Common Stock

NASDAQ:SNWV USA Medical Devices
Market Cap
$35.51 Million
Market Cap Rank
#23270 Global
#5078 in USA
Share Price
$4.13
Change (1 day)
-2.13%
52-Week Range
$4.00 - $16.47
All Time High
$16.47
About

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more